Literature DB >> 23196129

Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue.

Megha A Nagle1, Wei Wu, Satish A Eraly, Sanjay K Nigam.   

Abstract

Transporters in the choroid plexus (CP) regulate transport of numerous compounds of physiological and therapeutic interest between blood and CSF and thus likely play a key role in determining CNS levels of drugs, toxins and metabolites. Here, high CP expression was noted for the organic anion transporters, Oat1 (SLC22A6 or NKT) and Oat3 (SLC22A8) which are also the principal Oats in the renal proximal tubule, as well as SLC22A17, hypothesized to be involved in iron transport. Because Oat1 and Oat3 have overlapping substrate specificity, ex vivo preparations of CP from Oat1((-/-)) and Oat3((-/-)) mice were used to isolate the individual transport function of each, respectively. Tissue from either knockout mouse mediated the probenecid-inhibitable transport of the Oat substrate, 6-carboxyfluorescein (6CF), confirming the presence of Oat1 and Oat3 function. Because many antiviral medications are Oat substrates, including those crucial in the treatment of HIV infections, the interaction of the antivirals zidovudine, acyclovir, tenofovir, lamivudine, and stavudine, with Oat1 and Oat3 in CP, was investigated by determining the inhibition of 6CF uptake. All the antivirals tested manifested significant interaction with both Oat1 and Oat3, with the exception of stavudine which did not significantly affect Oat1 function. These results could have important implications for antiretroviral (and other drugs) penetration into or retention within the CNS, a major reservoir for virus during HIV infection. Apart from any effect at the blood brain barrier (BBB), designing specific inhibitors of Oat1 and Oat3 may be helpful in altering CNS drug levels by blocking organic anion transporters in the CP. The role of SLC22A17 in the CP deserves further exploration. The ability of Oats to regulate the movement of small molecules across the BBB, CP, proximal tubule and other tissues may also be important for their role in remote sensing and signaling [1,21]).
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23196129      PMCID: PMC3591490          DOI: 10.1016/j.neulet.2012.11.027

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

Review 1.  Epithelial pathways in choroid plexus electrolyte transport.

Authors:  Helle H Damkier; Peter D Brown; Jeppe Praetorius
Journal:  Physiology (Bethesda)       Date:  2010-08

2.  Tissue distribution and ontogeny of organic cation transporters in mice.

Authors:  Yazen Alnouti; Jay S Petrick; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2005-12-28       Impact factor: 3.922

3.  Molecular Trojan horses for blood-brain barrier drug delivery.

Authors:  William M Pardridge
Journal:  Discov Med       Date:  2006-08       Impact factor: 2.970

Review 4.  Role of drug efflux carriers in the healthy and diseased brain.

Authors:  Dirk M Hermann; Ertugrul Kilic; Annett Spudich; Stefanie D Krämer; Heidi Wunderli-Allenspach; Claudio L Bassetti
Journal:  Ann Neurol       Date:  2006-11       Impact factor: 10.422

5.  Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice.

Authors:  Satish A Eraly; Volker Vallon; Duke A Vaughn; Jon A Gangoiti; Kerstin Richter; Megha Nagle; Julio C Monte; Timo Rieg; David M Truong; Jeffrey M Long; Bruce A Barshop; Gregory Kaler; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2005-12-14       Impact factor: 5.157

6.  Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice.

Authors:  Douglas H Sweet; David S Miller; John B Pritchard; Yuko Fujiwara; David R Beier; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

Review 7.  Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis.

Authors:  Wei Wu; Ankur V Dnyanmote; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2011-02-11       Impact factor: 4.436

8.  Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination.

Authors:  David M Truong; Gregory Kaler; Akash Khandelwal; Peter W Swaan; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

9.  Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models.

Authors:  D H Sweet; S A Eraly; D A Vaughn; K T Bush; S K Nigam
Journal:  Kidney Int       Date:  2006-03       Impact factor: 10.612

10.  Choroid plexus controls brain availability of anti-HIV nucleoside analogs via pharmacologically inhibitable organic anion transporters.

Authors:  Nathalie Strazielle; Marie-Françoise Belin; Jean-François Ghersi-Egea
Journal:  AIDS       Date:  2003-07-04       Impact factor: 4.177

View more
  18 in total

1.  Organic Anion Transporter 1 Deficiency Accelerates Learning and Memory Impairment in tg2576 Mice by Damaging Dendritic Spine Morphology and Activity.

Authors:  Xinlin Wu; Jianqing Zhang; Heng Liu; Yansheng Mian; Birong Liang; Hongbo Xie; Shijun Zhang; Baoguo Sun; Houming Zhou
Journal:  J Mol Neurosci       Date:  2015-03-01       Impact factor: 3.444

Review 2.  The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.

Authors:  Sanjay K Nigam
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-01-06       Impact factor: 13.820

Review 3.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 4.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

Review 5.  HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities.

Authors:  Corbin G Thompson; Cynthia L Gay; Angela D M Kashuba
Journal:  AIDS Res Hum Retroviruses       Date:  2017-05-16       Impact factor: 2.205

Review 6.  SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers.

Authors:  Marilyn E Morris; Vivian Rodriguez-Cruz; Melanie A Felmlee
Journal:  AAPS J       Date:  2017-06-29       Impact factor: 4.009

7.  Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach.

Authors:  Henry C Liu; Anne Goldenberg; Yuchen Chen; Christina Lun; Wei Wu; Kevin T Bush; Natasha Balac; Paul Rodriguez; Ruben Abagyan; Sanjay K Nigam
Journal:  J Pharmacol Exp Ther       Date:  2016-08-03       Impact factor: 4.030

8.  An Organic Anion Transporter 1 (OAT1)-centered Metabolic Network.

Authors:  Henry C Liu; Neema Jamshidi; Yuchen Chen; Satish A Eraly; Sai Yee Cho; Vibha Bhatnagar; Wei Wu; Kevin T Bush; Ruben Abagyan; Bernhard O Palsson; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2016-07-20       Impact factor: 5.157

9.  The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis.

Authors:  Kevin T Bush; Wei Wu; Christina Lun; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2017-08-01       Impact factor: 5.157

10.  A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome.

Authors:  Amber Dahlin; Matthias Wittwer; Melanie de la Cruz; Jonathan M Woo; Rujuta Bam; Valeska Scharen-Guivel; John Flaherty; Adrian S Ray; Tomas Cihlar; Samir K Gupta; Kathleen M Giacomini
Journal:  Pharmacogenet Genomics       Date:  2015-02       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.